Reuters logo
BRIEF-Hansa Medical: preclinical results confirm IdeS potential in cancer immunotherapy
May 23, 2017 / 6:21 AM / 4 months ago

BRIEF-Hansa Medical: preclinical results confirm IdeS potential in cancer immunotherapy

May 23 (Reuters) - HANSA MEDICAL AB

* PUBLISHED PRECLINICAL RESULTS CONFIRM IDES POTENTIAL IN CANCER IMMUNOTHERAPY

* PUBLISHED PRECLINICAL RESULTS CONFIRM IDES POTENTIAL IN CANCER IMMUNOTHERAPY

* PUBLISHED FINDINGS DEMONSTRATE HOW PRE-TREATMENT WITH IDES IN TUMOUR ANIMAL MODELS CAN INCREASE EFFICACY OF CURRENTLY AVAILABLE ANTIBODY BASED CANCER THERAPIES Source text for Eikon: Further company coverage: (Gdynia Newsroom)

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below